Cochrane Collaboration

Lancaster Health Hub is committed to using the principles of evidence-based practice to support skill and capability development across the network. A substantial proportion of this has been achieved to date in the Hub to develop Cochrane systematic reviews of interventions. The following reviews are a sample of work published on the Cochrane Database of Systematic Reviews (Impact Factor 6.1):

 

  • Felix LM, Grundy S, Milan SJ, Armstrong R, Harrison H, Lynes D, Spencer D. Dual antibiotics for bronchiectasis. Cochrane Database of Systematic Reviews 2018, Issue 6. Art.No.:CD012514. DOI:10.1002/14651858.CD012514.pub2
  • Kelly C, Grundy S, Lynes D, Evans DJW, Gudur S, Milan SJ, Spencer S. Self-management for bronchiectasis. Cochrane Database of Systematic Reviews 2018, Issue 2. Art.No.: CD012528. DOI: 10/1002/14651858.pub2.
  • Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews 2017, Issue 11. Art No.:CD003898. DOI: 10.1002/14651858.CD0033898.pub6.
  • Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S. Macrolide antibiotics for bronchiectasis. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012406. DOI. 10.1002/14651858.CD012406.pub2
  • Farne AH, Wilson A, Powell C, Bax L, Milan SJ. Anti-IL5 therapies for asthma.  Cochrane Database of Systematic Reviews, 2017, Issue 9, Art. No.: CD010834. DOI: 10.1102/14651858.CD010834.pub3
  • Powell C, Milan SJ, Dwan K, Bax L, Walters N. Mepolizumab versus placebo for asthma. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No. : CD010834. DOI: 10.1002/14651858.CD010834.pub2  
  • Wilkinson M, Sugumar K, Milan SJ, Hart A, Crockett A, Crossingham I. Mucolytics for bronchiectasis Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD001289. DOI: 10.1002/14651858.CD001289.pub